General Information of Drug (ID: DMV5FN1)

Drug Name
NKS-01 Drug Info
Synonyms 14alpha-Hydroxy-4-androstene-3,6,17-trione
Indication
Disease Entry ICD 11 Status REF
Bladder cancer 2C94 Discontinued in Phase 2 [1]
Cross-matching ID
PubChem CID
6918079
CAS Number
CAS 120051-39-0
TTD Drug ID
DMV5FN1

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug(s) Targeting Aromatase (CYP19A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Anastrozole DMNP60F Breast cancer 2C60-2C65 Approved [3]
Letrozole DMH07Y3 Estrogen-receptor positive breast cancer Approved [4]
Exemestane DM9HPW3 Hormonally-responsive breast cancer 2C60-2C65 Approved [4]
Aminoglutethimide DMWFHMZ Cushing disease 5A70 Approved [5]
FADROZOLE DM3C5GZ Breast cancer 2C60-2C65 Approved [6]
Testolactone DMVY4GN Breast cancer 2C60-2C65 Approved [7]
LIAROZOLE DM4OYXE Dermatological disease DA24.Y Phase 2/3 [8]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [9]
BGS-649 DMO4MNQ Endometriosis GA10 Phase 2 [10]
NARINGENIN DMHAZLM N. A. N. A. Phase 1 [8]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aromatase (CYP19A1) TTSZLWK CP19A_HUMAN Inhibitor [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003076)
2 Effects of aromatase inhibitors on the pathobiology of the human breast, endometrial and ovarian carcinoma. Endocr Relat Cancer. 1999 Jun;6(2):197-204.
3 Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2002;15 Suppl 3:945-8.
4 Aromatase inhibitors--theoretical concept and present experiences in the treatment of endometriosis. Zentralbl Gynakol. 2003 Jul-Aug;125(7-8):247-51.
5 Aminoglutethimide-induced protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis. Chem Res Toxicol. 2007 Jul;20(7):1038-45.
6 Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach. J Med Chem. 2005 Nov 17;48(23):7282-9.
7 Aromatase inhibitors for male infertility. J Urol. 2002 Feb;167(2 Pt 1):624-9.
8 Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). Bioorg Med Chem Lett. 2010 May 15;20(10):3050-64.
9 Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template. J Med Chem. 2010 Mar 11;53(5):2155-70.
10 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032111)